Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**BASP1 pseudogene 1** (abbreviated BASP1P1) is classified as a pseudogene, which means it is a genomic DNA sequence similar to the functional BASP1 gene but is generally considered non-functional and does not encode an active protein. There is no evidence that BASP1P1 serves as a therapeutic target, is involved in disease, or interacts with drugs. No clear biological functions or roles in disease have been attributed to this pseudogene in the scientific literature. Pseudogenes such as BASP1P1 are typically studied in genomics for evolutionary and regulatory insights, but not as active molecular targets[5]. **Clarification of potential confusion:** - BASP1P1 should not be confused with its parental gene, **BASP1 (brain acid soluble protein 1)**, which is a well-characterized protein involved in transcriptional repression, cell differentiation, and has potential tumor suppressor roles[1][2][3][4][6]. However, BASP1P1 itself is not known to encode a protein or serve as a drug target. - There is no indication that the name is misspelled or refers to a distinct active protein-coding gene[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BASP1 pseudogene 1 (BASP1P1).